...
首页> 外文期刊>Resuscitation. >Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest.
【24h】

Thrombolytic treatment of acute myocardial infarction after out-of-hospital cardiac arrest.

机译:院外心脏骤停后的溶栓治疗急性心肌梗死。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To investigate the safety and efficacy of thrombolytic treatment for an acute myocardial infarction (AMI) immediately after resuscitation in the out-of-hospital setting. Design: Retrospective. Setting: A middle-sized urban city (population 540000) served by a single emergency medical system using a tiered response with physicians in field. Patients and methods: Sixty-eight patients with an initial diagnosis of AMI who received thrombolytic treatment in an out-of-hospital setting after cardiac arrest and cardiopulmonary resuscitation (CPR) between January 1st 1994 and December 31st 1998. An ECG and the myocardial enzymes (CK, CK-MB, Troponin-T) were used to diagnose AMI. Myocardial reperfusion was assessed by resolution of the ST-segment elevation. Side effects and complications were studied. The quality of secondary survival was evaluated. The Utstein style was used for a uniform style of reporting the cardiac arrest data. Results: The accuracy of prehospital diagnosis was found to be excellent. Retrospective analysis revealed that thrombolytic therapy had been appropriately administered in 64 (94%) of the 68 patients actually treated. Reperfusion was achieved in 71% of the patients. Haemorrhagic complications were few, and included intracranial haemorrhage (one patient), gastrointestinal bleeding (two patients), bleeding from the puncture site (one patient) and epistaxis (one patient). The incidence of hypotension during streptokinase infusion was 22%. Sixty-three (93%) of the patients were admitted alive to the hospital, with 36 subsequently surviving to discharge. Conclusions: Thrombolytic treatment is a safe and effective treatment in AMI even after out-of-hospital cardiopulmonary resuscitation.
机译:目的:探讨在院外急救后立即进行溶栓治疗急性心肌梗死(AMI)的安全性和有效性。设计:回顾性。地点:一个中等规模的城市(人口54万),由一个单一的紧急医疗系统提供服务,并与现场医生进行分层响应。患者和方法:1994年1月1日至1998年12月31日在心脏骤停和心肺复苏(CPR)后在院外环境中接受溶栓治疗的68例初次诊断为AMI的患者。ECG和心肌酶(CK,CK-MB,肌钙蛋白-T)用于诊断AMI。通过ST段抬高的分辨率评估心肌再灌注。研究了副作用和并发症。评估次要生存的质量。 Utstein样式用于报告心脏骤停数据的统一样式。结果:发现院前诊断的准确性极佳。回顾性分析显示,在实际治疗的68例患者中,有64例(94%)已适当实施了溶栓治疗。 71%的患者实现了再灌注。出血并发症很少,包括颅内出血(一名患者),胃肠道出血(两名患者),穿刺部位出血(一名患者)和鼻出血(一名患者)。链激酶注入过程中低血压的发生率为22%。六十三(93%)名患者还活着入院,随后有36名幸存者得以出院。结论:即使在院外进行心肺复苏后,溶栓治疗仍是一种安全有效的AMI治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号